Cooperative cell-growth inhibition by combination treatment with ZD1839 (Iressa) and trastuzumab (Herceptin) in non-small-cell lung cancer
Keywords: Heterodimer formation; Non-small-cell lung cancer; ZD1839; Trastuzumab;